Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
39.53
Nov 20 • 7:46 AM ET Dollar change-0.74 Percentage change(-1.84%)
Category
US Equities - Industry Sector
Sponsor
ARK Funds
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.75%
Inverse/Leveraged
IPO
Oct 31, 2014
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
Tags
-
Sector/Theme
Region
SMA20
-14.97%
SMA50
-19.32%
SMA200
3.11%
Return% 1Y
53.55%
Return% 3Y
20.05%
Return% 5Y
-10.82%
Return% 10Y
Return% SI
Flows% 1M
0.26%
Flows% 3M
12.67%
Flows% YTD
15.24%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
34
AUM
1.85B
NAV/sh
52W High
58.83 -32.81%
52W Low
24.60 60.69%
Volatility
5.09% 5.60%
ATR (14)
2.53
RSI (14)
33.37
Beta
1.79
Rel Volume
0.03
Avg Volume
5.04M
Volume
6,383
Perf Week
-8.50%
Perf Month
-17.42%
Perf Quarter
-17.66%
Perf Half Y
28.89%
Perf YTD
36.45%
Perf Year
45.28%
Perf 3Y
40.28%
Perf 5Y
-41.95%
Perf 10Y
128.53%
Prev Close
40.27
Price
39.53
Change %
-1.84%
ARK Genomic Revolution ETF seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.